Hims & Hers Health, Inc.
corporate_fare Company Profile
Hims & Hers Health, Inc. (NYSE:HIMS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 33 items for HIMS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for HIMS spans 8-K, 4, 10-Q.
Recent high-impact activity:
- FDA Warns on Compounded GLP-1s; Hims & Hers Slides 3.85%
- Hims Enters Australia, Targets $1B International Revenue
- Visa Warns Hims & Hers Over Weight-Loss Subscription Complaints
- Hims & Hers Posts $753M in Q2 Revenue, Debuts Full-Year Outlook at $3.1B–$3.3B
- Hims & Hers Issues First FY Revenue Outlook at $3.1B-$3.3B
Financial Snapshot
Short Interest & Short Volume
6.13 days to coverFINRA reported short interest of 52,920,443 shares in HIMS as of the September 15, 2026 settlement, a 3.7% decrease from the prior period — about 6.1 days to cover at its recent average daily volume. On October 2, 2026, 59.5% of HIMS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for HIMS, detected from its recent SEC filings · based on capital-structure filings through 2026-05-21.
Convertible Notes Issued · Favorable Conversion Terms
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →